These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9484844)

  • 21. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
    Moritake H; Horii Y; Kuroda H; Sugimoto T
    Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
    Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
    Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
    Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
    Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
    Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
    Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
    Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J
    Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
    Zainuddin N; Jaafar H; Isa MN; Abdullah JM
    Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mutation of PTEN in bladder carcinoma.
    Aveyard JS; Skilleter A; Habuchi T; Knowles MA
    Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
    Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
    Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
    Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W
    Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.